Salvia BioElectronics (SAL), NL

Salvia BioElectronics is a medical device company pioneering neuromodulation therapies for migraine. Salvia's unique, paper-thin implant is designed to reduce the frequency and intensity of migraine attacks by delivering gentle electrical pulses to the nerves associated with the condition. The company is currently in the clinical stage of development. In addition, Salvia is considering potential opportunities the device creates for the treatment of cluster headache and other neurological disorders. Salvia has received the Breakthrough Device Designation from the United States Food and Drug Administration (FDA), which facilitates expedited market access for devices that treat life-threatening or irreversibly debilitating conditions.

Salvia has lab infrastructure in place for pilot manufacturing of implantable medical devices, as well as validated test protocols and infrastructure for performance verification of the conformal soft encapsulated electronics on both reference structures and implantable devices. In collaboration with IMEC, Salvia will contribute to the highly efficient wireless (inductive) powering of the shallow implant, as well as system definition and circuit integration into few components to ensure long-term reliability. Additionally, Salvia will work closely with FIZM, Acquandas and TUD on the implantable system integration using highly miniaturized and conformal PDMS encapsulation of the implant electronics.